VIDEO: Lutikizumab effective in HS patients, new study shows
- Jeremy Visser
- Apr 3, 2024
- 1 min read
According to a recent study, lutikizumab 300 mg was shown to be more effective than placebo in hidradenitis suppurativa (HS) patients.
top of page
it's where dermatology lives
bottom of page
Comments